Table 2.
Variables correlated to serum arylesterase activity | Non-diabetic patients with HF | Diabetic patients with HF | |||
---|---|---|---|---|---|
Correlation coefficient | P-value | Correlation coefficient | P-value | ||
Unadjusted | Age | −0.371 | <0.001 | −0.216 | 0.056 |
Log HbA1c | 0.035 | 0.699 | 0.068 | 0.554 | |
Total cholesterol | 0.171 | 0.055 | 0.212 | 0.068 | |
HDL cholesterol | 0.270 | 0.002 | 0.111 | 0.344 | |
ApoA-I | 0.257 | 0.004 | 0.255 | 0.028 | |
eGFR | 0.142 | 0.100 | 0.190 | 0.096 | |
Log NT-proBNP | −0.257 | 0.004 | −0.353 | 0.003 | |
Log LVEF | 0.098 | 0.254 | 0.303 | 0.007 | |
NYHA class | −0.301 | <0.001 | −0.474 | <0.001 | |
Adjusted* | Log NT-proBNP | −0.227 | 0.035 | −0.313 | 0.025 |
Log LVEF | 0.089 | 0.415 | 0.325 | 0.020 | |
NYHA class | −0.451 | <0.001 | −0.554 | <0.001 |
HF, heart failure; HbA1c, glycated hemoglobin A1c; eGFR, estimated glomerular filtration rate; hsCRP, high-sentivity C-reactive protein; NT-proBNP, N-terminal pro-B-type natriuretic peptide; LVEF, left ventricular ejection fraction.
*After adjustment for ages, sex, log transformed hsCRP, eGFR, apo A-I, history of smoking, hypertension and myocardial infarction.